1. Home
  2. BYFC vs VNRX Comparison

BYFC vs VNRX Comparison

Compare BYFC & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYFC
  • VNRX
  • Stock Information
  • Founded
  • BYFC 1946
  • VNRX N/A
  • Country
  • BYFC United States
  • VNRX United States
  • Employees
  • BYFC N/A
  • VNRX N/A
  • Industry
  • BYFC Savings Institutions
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • BYFC Finance
  • VNRX Health Care
  • Exchange
  • BYFC Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • BYFC 64.1M
  • VNRX 67.2M
  • IPO Year
  • BYFC 1996
  • VNRX N/A
  • Fundamental
  • Price
  • BYFC $7.05
  • VNRX $0.64
  • Analyst Decision
  • BYFC
  • VNRX Strong Buy
  • Analyst Count
  • BYFC 0
  • VNRX 4
  • Target Price
  • BYFC N/A
  • VNRX $4.17
  • AVG Volume (30 Days)
  • BYFC 6.7K
  • VNRX 524.2K
  • Earning Date
  • BYFC 10-29-2024
  • VNRX 11-14-2024
  • Dividend Yield
  • BYFC N/A
  • VNRX N/A
  • EPS Growth
  • BYFC N/A
  • VNRX N/A
  • EPS
  • BYFC 0.28
  • VNRX N/A
  • Revenue
  • BYFC $35,113,000.00
  • VNRX $1,285,827.00
  • Revenue This Year
  • BYFC N/A
  • VNRX $180.66
  • Revenue Next Year
  • BYFC N/A
  • VNRX $558.69
  • P/E Ratio
  • BYFC $24.70
  • VNRX N/A
  • Revenue Growth
  • BYFC 12.14
  • VNRX 97.50
  • 52 Week Low
  • BYFC $4.41
  • VNRX $0.43
  • 52 Week High
  • BYFC $7.99
  • VNRX $1.23
  • Technical
  • Relative Strength Index (RSI)
  • BYFC 54.16
  • VNRX 49.57
  • Support Level
  • BYFC $7.01
  • VNRX $0.57
  • Resistance Level
  • BYFC $7.24
  • VNRX $0.68
  • Average True Range (ATR)
  • BYFC 0.14
  • VNRX 0.08
  • MACD
  • BYFC -0.00
  • VNRX -0.00
  • Stochastic Oscillator
  • BYFC 60.00
  • VNRX 58.40

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: